Corvus Pharmaceuticals (CRVS) Short Interest Ratio & Short Volume $3.47 -0.16 (-4.41%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$3.46 -0.01 (-0.29%) As of 08:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Corvus Pharmaceuticals Short Interest DataCorvus Pharmaceuticals (CRVS) has a short interest of 5.77 million shares. This marks a 8.05% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.2, indicating that it would take 6.2 days of the average trading volume of 723,912 shares to cover all short positions.Current Short Interest5,770,000 sharesPrevious Short Interest5,340,000 sharesChange Vs. Previous Month+8.05%Dollar Volume Sold Short$20.71 millionShort Interest Ratio6.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares68,169,000 sharesPercentage of Shares Shorted8.46%Today's Trading Volume547,212 sharesAverage Trading Volume723,912 sharesToday's Volume Vs. Average76% Short Selling Corvus Pharmaceuticals? Sign up to receive the latest short interest report for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRVS Short Interest Over TimeCRVS Days to Cover Over TimeCRVS Percentage of Float Shorted Over Time Corvus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20255,770,000 shares $20.71 million +8.1%N/A6.2 $3.59 4/15/20255,340,000 shares $17.30 million +8.5%12.1%7.8 $3.24 3/31/20254,920,000 shares $15.65 million -8.7%11.1%7.9 $3.18 3/15/20255,390,000 shares $24.36 million +0.8%12.2%6.2 $4.52 2/28/20255,350,000 shares $21.61 million -6.6%12.1%5.8 $4.04 2/15/20255,730,000 shares $27.96 million -6.2%13.0%6.2 $4.88 1/31/20256,110,000 shares $32.75 million +11.1%N/A6.2 $5.36 1/15/20255,500,000 shares $27.06 million +1.3%N/A4.9 $4.92 12/31/20245,430,000 shares $29.05 million +26.0%N/A4.7 $5.35 12/15/20244,310,000 shares $31.81 million +22.8%N/A4 $7.38 Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/20243,510,000 shares $31.91 million +6.4%N/A4.5 $9.09 11/15/20243,300,000 shares $27.03 million +12.6%N/A4.5 $8.19 10/31/20242,930,000 shares $25.90 million +20.1%N/A4.6 $8.84 10/15/20242,440,000 shares $16.40 million +13.5%N/A4.6 $6.72 9/30/20242,150,000 shares $11.35 million +31.1%N/A5.4 $5.28 9/15/20241,640,000 shares $8.36 million +14.7%N/A4.5 $5.10 8/31/20241,430,000 shares $6.41 million +4.4%N/A4.9 $4.48 8/15/20241,370,000 shares $5.21 million +19.1%N/A5.3 $3.80 7/31/20241,150,000 shares $2.96 million -8.0%N/A4.7 $2.57 7/15/20241,250,000 shares $2.50 million -12.6%N/A5.8 $2.00 6/30/20241,430,000 shares $2.60 million -4.7%N/A6.6 $1.82 6/15/20241,500,000 shares $3.06 million -1.3%N/A6.5 $2.04 5/31/20241,520,000 shares $3.28 million +17.8%N/A6.5 $2.16 5/15/20241,290,000 shares $2.86 million -5.2%N/A5.2 $2.22 4/30/20241,360,000 shares $2.11 million -0.7%3.7%5.4 $1.55 4/15/20241,370,000 shares $2.01 million -2.1%3.7%7 $1.47 3/31/20241,400,000 shares $2.49 million -6.0%3.8%6.6 $1.78 3/15/20241,490,000 shares $2.83 million +17.3%4.0%6.8 $1.90 2/29/20241,270,000 shares $2.84 million No Change3.4%5.7 $2.24 2/15/20241,270,000 shares $2.98 million -8.0%3.4%6.2 $2.35 1/31/20241,380,000 shares $2.76 million -1.4%3.7%6.3 $2.00 1/15/20241,400,000 shares $3.28 million +5.3%3.8%6 $2.34 12/31/20231,330,000 shares $2.34 million +2.3%3.6%6.1 $1.76 12/15/20231,300,000 shares $1.99 million -17.2%3.5%6.5 $1.53 11/30/20231,570,000 shares $2.40 million -12.3%4.3%7.9 $1.53 11/15/20231,790,000 shares $2.70 million +4.7%4.9%6.4 $1.51 10/31/20231,710,000 shares $1.93 million -3.4%4.6%6.4 $1.13 10/15/20231,770,000 shares $2.48 million No Change4.8%7.1 $1.40 9/30/20231,770,000 shares $2.58 million -2.8%4.8%6.1 $1.46 9/15/20231,820,000 shares $2.88 million +32.9%4.9%5 $1.58July 2025 Rule Change to Impact Retirement Investors (Ad)There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.Yes, Send Me My FREE Retirement Guide 8/31/20231,370,000 shares $2.90 million +21.2%3.8%2.3 $2.12 8/15/20231,130,000 shares $2.44 million -2.6%3.1%1.8 $2.16 7/31/20231,160,000 shares $2.61 million -17.7%3.4%1.1 $2.25 7/15/20231,410,000 shares $3.47 million +11.9%4.1%1.3 $2.46 6/30/20231,260,000 shares $2.89 million +61.4%3.7%1.1 $2.29 6/15/2023780,600 shares $1.94 million -19.8%2.3%0.7 $2.49 5/31/2023973,100 shares $2.96 million +113.6%2.8%1.1 $3.04 5/15/2023455,500 shares $1.18 million +209.2%1.3%0.6 $2.60 4/30/2023147,300 shares $159,084.00 -38.3%0.4%0.6 $1.08 4/15/2023238,700 shares $248,248.00 +50.8%0.7%1.1 $1.04 3/31/2023158,300 shares $144,053.00 -20.9%0.5%0.8 $0.91 3/15/2023200,200 shares $144,144.00 +16.9%0.6%2.1 $0.72 2/28/2023171,200 shares $124,976.00 +35.9%0.5%1.4 $0.73 2/15/2023126,000 shares $97,007.40 +13.7%0.4%1 $0.77 1/31/2023110,800 shares $90,856.00 -34.9%0.3%0.8 $0.82 1/15/2023170,100 shares $154,791.00 -3.7%0.5%1.2 $0.91 12/30/2022176,700 shares $150,195.00 +17.3%0.5%1.2 $0.85 12/15/2022150,600 shares $126,353.40 -53.8%0.4%1 $0.84 11/30/2022325,900 shares $303,803.98 +58.1%0.9%2.2 $0.93 11/15/2022206,100 shares $187,963.20 -0.5%0.6%1.3 $0.91 10/31/2022207,100 shares $179,555.70 -12.4%0.6%1 $0.87 10/15/2022236,500 shares $215,215.00 +16.3%0.7%0.9 $0.91 9/30/2022203,300 shares $166,401.05 +1.6%0.6%0.7 $0.82 9/15/2022200,200 shares $191,191.00 +70.8%0.6%0.6 $0.96 8/31/2022117,200 shares $112,336.20 -64.5%0.3%0.4 $0.96 8/15/2022330,500 shares $371,812.50 -75.2%1.0%1.1 $1.13 7/31/20221,330,000 shares $1.17 million +70.1%3.9%4.7 $0.88 7/15/2022782,000 shares $774,962.00 -15.2%2.3%3.2 $0.99 6/30/2022922,500 shares $913,367.25 +306.2%2.7%3.6 $0.99 6/15/2022227,100 shares $224,806.29 +18.5%0.7%0.9 $0.99 5/31/2022191,600 shares $197,348.00 -22.9%0.6%0.8 $1.03 5/15/2022248,600 shares $258,544.00 +28.6%0.7%1 $1.04 4/30/2022193,300 shares $253,223.00 +5.2%0.6%0.8 $1.31 4/15/2022183,800 shares $266,510.00 -14.9%0.5%0.7 $1.45 3/31/2022215,900 shares $354,076.00 +5.2%0.6%0.7 $1.64 3/15/2022205,200 shares $299,592.00 +3.0%0.6%0.6 $1.46 2/28/2022199,200 shares $352,584.00 -41.3%0.6%0.5 $1.77 2/15/2022339,300 shares $692,172.00 +101.5%1.0%0.7 $2.04 1/31/2022168,400 shares $303,120.00 -43.8%0.5%0.3 $1.80 1/15/2022299,500 shares $673,875.00 +34.0%N/A0 $2.25 12/31/2021223,500 shares $538,635.00 -31.2%0.7%0.3 $2.41 12/15/2021324,700 shares $892,925.00 -43.0%1.0%0.2 $2.75 11/30/2021569,200 shares $1.94 million -45.8%1.9%0.1 $3.41 11/15/20211,050,000 shares $3.89 million -42.9%3.5%0.1 $3.70 10/29/20211,840,000 shares $8.34 million +3.4%6.2%0.2 $4.53 10/15/20211,780,000 shares $8.81 million -42.2%6.3%0.2 $4.95 9/30/20213,080,000 shares $14.91 million +318.7%10.9%0.4 $4.84 9/15/2021735,600 shares $1.68 million +45.0%2.5%0.1 $2.29 8/31/2021507,200 shares $1.15 million -48.0%1.8%2.1 $2.26 8/13/2021975,800 shares $1.93 million -22.6%3.5%4.4 $1.98Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 7/30/20211,260,000 shares $2.63 million +3.3%4.5%5.3 $2.09 7/15/20211,220,000 shares $2.84 million +0.8%3.7%4.1 $2.33 6/30/20211,210,000 shares $3.23 million +7.1%3.7%4.2 $2.67 6/15/20211,130,000 shares $3.10 million -8.9%3.4%3.5 $2.74 5/28/20211,240,000 shares $3.40 million +3.3%3.8%3.4 $2.74 5/14/20211,200,000 shares $2.95 million -9.1%N/A2.1 $2.46 4/30/20211,320,000 shares $3.72 million -1.5%N/A1.4 $2.82 4/15/20211,340,000 shares $3.79 million -7.6%N/A1.5 $2.83 3/31/20211,450,000 shares $4.26 million -8.2%N/A1.6 $2.94 3/15/20211,580,000 shares $5.10 million +24.4%N/A1.8 $3.23 2/26/20211,270,000 shares $4.55 million +2.4%N/A1.5 $3.58 2/12/20211,240,000 shares $4.89 million +0.8%N/A1.8 $3.94 1/29/20211,230,000 shares $4.54 million No Change5.7%5 $3.69 1/15/20211,230,000 shares $5.08 million +2.5%5.7%6.6 $4.13 12/31/20201,200,000 shares $4.52 million -3.2%5.6%6.8 $3.77 12/15/20201,240,000 shares $4.90 million -10.1%5.8%1.5 $3.95 11/30/20201,380,000 shares $5.56 million -0.7%6.4%1.6 $4.03 11/15/20201,390,000 shares $5.74 million -9.2%6.5%1.6 $4.13 10/30/20201,530,000 shares $6.10 million +2.7%7.1%1.7 $3.99 10/15/20201,490,000 shares $5.96 million +8.8%6.9%1.6 $4.00 9/30/20201,370,000 shares $5.49 million -14.4%6.4%1.3 $4.01 9/15/20201,600,000 shares $6.75 million -1.2%7.5%0.8 $4.22 8/31/20201,620,000 shares $6.14 million +2.5%7.6%0.8 $3.79 8/14/20201,580,000 shares $6.35 million -2.5%7.4%0.8 $4.02 7/31/20201,620,000 shares $6.87 million +25.6%7.6%0.8 $4.24 7/15/20201,290,000 shares $4.91 million +204.1%6.0%0.6 $3.81 6/30/2020424,200 shares $1.15 million +0.3%2.1%0.2 $2.72 6/15/2020422,900 shares $1.31 million +29.0%2.1%3.2 $3.10 5/29/2020327,800 shares $1.20 million -72.5%1.7%2.2 $3.66 CRVS Short Interest - Frequently Asked Questions What is Corvus Pharmaceuticals' current short interest? Short interest is the volume of Corvus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 5,770,000 shares of CRVS short. Learn More on Corvus Pharmaceuticals' current short interest. What is a good short interest ratio for Corvus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRVS shares currently have a short interest ratio of 6.0. Learn More on Corvus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Corvus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corvus Pharmaceuticals: Jane Street Group LLC, Millennium Management LLC, ADAR1 Capital Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Corvus Pharmaceuticals' short interest increasing or decreasing? Corvus Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 5,770,000 shares, an increase of 8.1% from the previous total of 5,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Corvus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Corvus Pharmaceuticals: Wave Life Sciences Ltd. (8.59%), Gyre Therapeutics, Inc. (13.99%), Phibro Animal Health Co. (4.52%), Mineralys Therapeutics, Inc. (16.91%), Collegium Pharmaceutical, Inc. (14.75%), Syndax Pharmaceuticals, Inc. (25.17%), Arcus Biosciences, Inc. (12.18%), Enliven Therapeutics, Inc. (21.79%), Avadel Pharmaceuticals plc (10.52%), Spyre Therapeutics, Inc. (24.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Corvus Pharmaceuticals stock? Short selling CRVS is an investing strategy that aims to generate trading profit from Corvus Pharmaceuticals as its price is falling. CRVS shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corvus Pharmaceuticals? A short squeeze for Corvus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRVS, which in turn drives the price of the stock up even further. How often is Corvus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRVS, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies WVE Short Interest Data GYRE Short Interest Data PAHC Short Interest Data MLYS Short Interest Data COLL Short Interest Data SNDX Short Interest Data RCUS Short Interest Data ELVN Short Interest Data AVDL Short Interest Data SYRE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRVS) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRVS Stock Free CRVS Stock Alerts